Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

Markets & Finance

Legg Mason Downgrades Chemed Corp.

Legg Mason downgrades Chemed Corp. (CHE) to hold from buy.

Analyst Eric Gommel says the stock is fully valued. He notes the stock is up 21% on a split-adjusted basis since the company posted earnings May 3, is now above his $43.50 target.

He still likes the company's VITAS hospice business and notes the business is the oldest and largest for-profit hospice provider in the U.S., with a deep presence in major metropolitan markets and in key states such as Florida.

Gommel thinks VITAS already has infrastructure built to handle its growth and does not have issues with Medicare caps that other public players have had to endure. He maintains his $1.75 2005 earnings per share estimate and his $2.17 2006 earnings per share estimate.

blog comments powered by Disqus